argenx SE Sustainability Reports
argenx SE is a global clinical-stage biopharmaceutical company specializing in immunology. It focuses on developing antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
Sector: Manufacturing
Country: Netherlands
Exchange: Euronext Brussels
LEI: 7245009C5FZE6G9ODQ71
FIGI: BBG001V0GFM7
17 reports from 2014 to 2025
